FGFR1 Expression and Role in Migration in Low and High Grade Pediatric Gliomas

Naomi Egbivwie, Julia V. Cockle, Matthew Humphries, Azzam Ismail, Filomena Esteves, Katherine Karakoula, Ruth Morton, Tracy Warr, Susan C Short, Anke Bruning-Richardson

Research output: Contribution to journalArticle

Abstract

The heterogeneous and invasive nature of pediatric gliomas poses significant treatment challenges, highlighting the importance of identifying novel chemotherapeutic targets. Recently, recurrent Fibroblast growth factor receptor 1 (FGFR1) mutations in pediatric gliomas have been reported. Here, we explored the clinical relevance of FGFR1 expression, cell migration in low and high grade pediatric gliomas and the role of FGFR1 in cell migration/invasion as a potential chemotherapeutic target. A high density tissue microarray (TMA) was used to investigate associations between FGFR1 and activated phosphorylated FGFR1 (pFGFR1) expression and various clinicopathologic parameters. Expression of FGFR1 and pFGFR1 were measured by immunofluorescence and by immunohistochemistry (IHC) in 3D spheroids in five rare patient-derived pediatric low-grade glioma (pLGG) and two established high-grade glioma (pHGG) cell lines. Two-dimensional (2D) and three-dimensional (3D) migration assays were performed for migration and inhibitor studies with three FGFR1 inhibitors. High FGFR1 expression was associated with age, malignancy, tumor location and tumor grade among astrocytomas. Membranous pFGFR1 was associated with malignancy and tumor grade. All glioma cell lines exhibited varying levels of FGFR1 and pFGFR1 expression and migratory phenotypes. There were significant anti-migratory effects on the pHGG cell lines with inhibitor treatment and anti-migratory or pro-migratory responses to FGFR1 inhibition in the pLGGs. Our findings support further research to target FGFR1 signaling in pediatric gliomas.

Original languageEnglish
Article number103
Number of pages17
JournalFrontiers in Oncology
Volume9
Issue numberMAR
DOIs
Publication statusPublished - 13 Mar 2019

Fingerprint

Receptor, Fibroblast Growth Factor, Type 1
Glioma
Pediatrics
Neoplasms
Cell Line
Cell Movement
Astrocytoma
Fluorescent Antibody Technique

Cite this

Egbivwie, Naomi ; Cockle, Julia V. ; Humphries, Matthew ; Ismail, Azzam ; Esteves, Filomena ; Karakoula, Katherine ; Morton, Ruth ; Warr, Tracy ; Short, Susan C ; Bruning-Richardson, Anke. / FGFR1 Expression and Role in Migration in Low and High Grade Pediatric Gliomas. In: Frontiers in Oncology. 2019 ; Vol. 9, No. MAR.
@article{ac8023d9fe5b4d2385f0418dc5188333,
title = "FGFR1 Expression and Role in Migration in Low and High Grade Pediatric Gliomas",
abstract = "The heterogeneous and invasive nature of pediatric gliomas poses significant treatment challenges, highlighting the importance of identifying novel chemotherapeutic targets. Recently, recurrent Fibroblast growth factor receptor 1 (FGFR1) mutations in pediatric gliomas have been reported. Here, we explored the clinical relevance of FGFR1 expression, cell migration in low and high grade pediatric gliomas and the role of FGFR1 in cell migration/invasion as a potential chemotherapeutic target. A high density tissue microarray (TMA) was used to investigate associations between FGFR1 and activated phosphorylated FGFR1 (pFGFR1) expression and various clinicopathologic parameters. Expression of FGFR1 and pFGFR1 were measured by immunofluorescence and by immunohistochemistry (IHC) in 3D spheroids in five rare patient-derived pediatric low-grade glioma (pLGG) and two established high-grade glioma (pHGG) cell lines. Two-dimensional (2D) and three-dimensional (3D) migration assays were performed for migration and inhibitor studies with three FGFR1 inhibitors. High FGFR1 expression was associated with age, malignancy, tumor location and tumor grade among astrocytomas. Membranous pFGFR1 was associated with malignancy and tumor grade. All glioma cell lines exhibited varying levels of FGFR1 and pFGFR1 expression and migratory phenotypes. There were significant anti-migratory effects on the pHGG cell lines with inhibitor treatment and anti-migratory or pro-migratory responses to FGFR1 inhibition in the pLGGs. Our findings support further research to target FGFR1 signaling in pediatric gliomas.",
keywords = "FGFR1, Immunohistochemistry, Inhibitors, Migration, Pediatric gliomas",
author = "Naomi Egbivwie and Cockle, {Julia V.} and Matthew Humphries and Azzam Ismail and Filomena Esteves and Katherine Karakoula and Ruth Morton and Tracy Warr and Short, {Susan C} and Anke Bruning-Richardson",
year = "2019",
month = "3",
day = "13",
doi = "10.3389/fonc.2019.00103",
language = "English",
volume = "9",
journal = "Frontiers in Oncology",
issn = "2234-943X",
publisher = "Frontiers Media S.A.",
number = "MAR",

}

Egbivwie, N, Cockle, JV, Humphries, M, Ismail, A, Esteves, F, Karakoula, K, Morton, R, Warr, T, Short, SC & Bruning-Richardson, A 2019, 'FGFR1 Expression and Role in Migration in Low and High Grade Pediatric Gliomas', Frontiers in Oncology, vol. 9, no. MAR, 103. https://doi.org/10.3389/fonc.2019.00103

FGFR1 Expression and Role in Migration in Low and High Grade Pediatric Gliomas. / Egbivwie, Naomi; Cockle, Julia V.; Humphries, Matthew; Ismail, Azzam; Esteves, Filomena; Karakoula, Katherine; Morton, Ruth; Warr, Tracy; Short, Susan C; Bruning-Richardson, Anke.

In: Frontiers in Oncology, Vol. 9, No. MAR, 103, 13.03.2019.

Research output: Contribution to journalArticle

TY - JOUR

T1 - FGFR1 Expression and Role in Migration in Low and High Grade Pediatric Gliomas

AU - Egbivwie, Naomi

AU - Cockle, Julia V.

AU - Humphries, Matthew

AU - Ismail, Azzam

AU - Esteves, Filomena

AU - Karakoula, Katherine

AU - Morton, Ruth

AU - Warr, Tracy

AU - Short, Susan C

AU - Bruning-Richardson, Anke

PY - 2019/3/13

Y1 - 2019/3/13

N2 - The heterogeneous and invasive nature of pediatric gliomas poses significant treatment challenges, highlighting the importance of identifying novel chemotherapeutic targets. Recently, recurrent Fibroblast growth factor receptor 1 (FGFR1) mutations in pediatric gliomas have been reported. Here, we explored the clinical relevance of FGFR1 expression, cell migration in low and high grade pediatric gliomas and the role of FGFR1 in cell migration/invasion as a potential chemotherapeutic target. A high density tissue microarray (TMA) was used to investigate associations between FGFR1 and activated phosphorylated FGFR1 (pFGFR1) expression and various clinicopathologic parameters. Expression of FGFR1 and pFGFR1 were measured by immunofluorescence and by immunohistochemistry (IHC) in 3D spheroids in five rare patient-derived pediatric low-grade glioma (pLGG) and two established high-grade glioma (pHGG) cell lines. Two-dimensional (2D) and three-dimensional (3D) migration assays were performed for migration and inhibitor studies with three FGFR1 inhibitors. High FGFR1 expression was associated with age, malignancy, tumor location and tumor grade among astrocytomas. Membranous pFGFR1 was associated with malignancy and tumor grade. All glioma cell lines exhibited varying levels of FGFR1 and pFGFR1 expression and migratory phenotypes. There were significant anti-migratory effects on the pHGG cell lines with inhibitor treatment and anti-migratory or pro-migratory responses to FGFR1 inhibition in the pLGGs. Our findings support further research to target FGFR1 signaling in pediatric gliomas.

AB - The heterogeneous and invasive nature of pediatric gliomas poses significant treatment challenges, highlighting the importance of identifying novel chemotherapeutic targets. Recently, recurrent Fibroblast growth factor receptor 1 (FGFR1) mutations in pediatric gliomas have been reported. Here, we explored the clinical relevance of FGFR1 expression, cell migration in low and high grade pediatric gliomas and the role of FGFR1 in cell migration/invasion as a potential chemotherapeutic target. A high density tissue microarray (TMA) was used to investigate associations between FGFR1 and activated phosphorylated FGFR1 (pFGFR1) expression and various clinicopathologic parameters. Expression of FGFR1 and pFGFR1 were measured by immunofluorescence and by immunohistochemistry (IHC) in 3D spheroids in five rare patient-derived pediatric low-grade glioma (pLGG) and two established high-grade glioma (pHGG) cell lines. Two-dimensional (2D) and three-dimensional (3D) migration assays were performed for migration and inhibitor studies with three FGFR1 inhibitors. High FGFR1 expression was associated with age, malignancy, tumor location and tumor grade among astrocytomas. Membranous pFGFR1 was associated with malignancy and tumor grade. All glioma cell lines exhibited varying levels of FGFR1 and pFGFR1 expression and migratory phenotypes. There were significant anti-migratory effects on the pHGG cell lines with inhibitor treatment and anti-migratory or pro-migratory responses to FGFR1 inhibition in the pLGGs. Our findings support further research to target FGFR1 signaling in pediatric gliomas.

KW - FGFR1

KW - Immunohistochemistry

KW - Inhibitors

KW - Migration

KW - Pediatric gliomas

UR - http://www.scopus.com/inward/record.url?scp=85063273700&partnerID=8YFLogxK

U2 - 10.3389/fonc.2019.00103

DO - 10.3389/fonc.2019.00103

M3 - Article

VL - 9

JO - Frontiers in Oncology

JF - Frontiers in Oncology

SN - 2234-943X

IS - MAR

M1 - 103

ER -

Egbivwie N, Cockle JV, Humphries M, Ismail A, Esteves F, Karakoula K et al. FGFR1 Expression and Role in Migration in Low and High Grade Pediatric Gliomas. Frontiers in Oncology. 2019 Mar 13;9(MAR). 103. https://doi.org/10.3389/fonc.2019.00103